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I

n humans, 80-90% of required vitamin D
is made in the skin upon sun exposure and
the remaining 10-20% is ingested in fish,
eggs and fortified dairy products. In the liver,
vitamins D2(ergocalciferol) and D3(cholecalciferol) are converted into 25-hydroxyvitamin D2
(25[OH]D2) and 25-hydroxyvitamin D3 (25(OH]
D3), respectively (1). In the kidney, 25(OH)D is
converted to its biologically active form 1,25-dihydroxyvitamin D (1,25[OH]2D) by 1α-hydroxylase. The serum level of 25(OH)D is used to
determine vitamin D status and normally ranges
between 30-100 ng/mL (75–250 nmol/L). Vitamin D insufficiency and deficiency are defined
as serum 25(OH)D levels of 20-30 mg/dL (5075 nmol/L) and <20 ng/mL (50 nmol/L), respectively (2). The critical role of 1,25(OH)2D
in calcium and phosphorus homeostasis is well
established (1,2). Accumulating evidence indicates that vitamin D also plays an important role
in regulating the blood pressure.

A recent randomized, double-blind, placebo controlled study conducted by Nasri et al. demonstrated that oral supplementation of vitamin D led to a
decrease in the blood pressure in individuals with
diabetes mellitus (3). Sixty individuals were randomized to receive either vitamin D3 50,000 IU
per week (n=30) or placebo (n=30) for 12 weeks.
Five individuals (8.3%) had vitamin D deficiency
and 27 others (45%) had vitamin D insufficiency. Vitamin D supplementation increased serum
25(OH)D levels from 84±52 nmol/L to 164±57
nmol/L (P= 0.001). Vitamin D supplementation led to a decrease in both systolic (121±13
to 110±9 mm Hg; P= 0.001) and diastolic blood
pressure (81±8 to 76±7 mm Hg, P= 0.046). No
statistically significant change in blood pressure
was observed in the placebo group.
The pivotal role of the renin-angiotensin system
in the regulation of the blood pressure is well
established (Figure 1). Renin is secreted by the
juxtaglomerular cells of the kidney in response
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Figure 1. The effects of vitamin D on the renin-angiotensin system. 1,25-dihydroxyvitamin D suppresses renin
gene expression, thereby inhibiting the renin-angiotensin
system. ACE, angiotensin-converting enzyme; H2O, water;
Na, sodium.

to decreased renal blood flow. It converts plasma angiotensinogen to angiotensin I, which is
then converted to angiotensin II by angiotensin-converting enzyme. Angiotensin II leads to
increased water and sodium reabsorption in the
kidney and vasoconstriction. Mounting evidence indicates that vitamin D regulates the renin-angiotensin system. An inverse relationship
between the blood pressure and serum 25(OH)
D levels has been documented in a number of
the epidemiological studies (4,5). In a cross-sectional study, Forman et al. explored the relation
between 25(OH)D and the renin-angiotensin system in 184 individuals with normal blood pressure (6). Compared with vitamin D-sufficient
individuals, those with vitamin D deficiency and
insufficiency had greater plasma angiotensin II
levels and a trend for higher plasma renin activity.
In addition, the activity of the renin-angiotensin
system in the kidney, as measured by the renal
plasma flow in response to angiotensin II infusion, was greater in vitamin D-deficient than in
42
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vitamin D-sufficient individuals. These results
suggested that decreased plasma 25(OH)D levels
were associated with increased activity of the renin angiotensin system. Resnick et al. investigated the relation between the plasma renin activity
and calcium-regulating hormones including calcitonin, 1,25(OH)2D3 and parathyroid hormone in
51 individuals with essential hypertension (7). An
inverse relation of the serum 1,25(OH)2D3 level
to the plasma renin activity (r= −0.65, P< 0.001)
was observed. This study corroborated a link between calcium homeostasis, vitamin D metabolism and the renin-angiotensin system.
To unravel the molecular mechanisms involved in
vitamin D-mediated regulation of the renin-angiotensin system, mice with loss-of-function mutations involving vitamin D receptor gene (VDRnull mice) were examined. The VDR-null mice
develop hypocalcemia at 3 weeks of age, hyperparathyroidism, rickets and osteomalacia (8). Li
et al. demonstrated that renin gene expression in
the kidney and angiotensin II levels in the plasma
were substantially increased in the VDR-null mice
leading to hypertension and cardiac hypertrophy
(9). In wild-type mice, pharmacological inhibition of 1,25(OH)2D3 synthesis led to an increase
in renin gene expression, whereas 1,25(OH)2D3
treatment suppressed renin expression. Similarly, 1,25(OH)2D3 markedly suppressed renin gene
expression in cultured cells by a VDR-mediated
mechanism. These investigators also demonstrated that the effect of vitamin D on renin gene
expression was independent of calcium metabolism. The authors concluded that 1,25(OH)2D3
is a negative regulator of the renin-angiotensin system. Subsequently, it was shown that
1,25(OH)2D3 suppressed renin gene expression
by binding to the transcription factor cAMP response element-binding protein (CREB), thereby
suppressing the activity of the cAMP response
element in the renin gene promoter (10).
To determine whether the inhibitory effects of
1,25(OH)2D on the renin-angiotensin system is
dependent on calcium or phosphorous, Zhou el
al. examined the effects of dietary interventions
www.nephropathol.com
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in 1α-hydroxylase knockout mice. Phenotypically resembling VDR-null mice, 1α-hydroxylase
knockout mice demonstrate undetectable serum
1,25(OH)2D levels and develop hypocalcemia,
hypophosphatemia, secondary hyperparathyroidism, growth retardation and skeletal abnormalities characteristic of rickets (11). Zhou et al.
demonstrated that 1α-hydroxylase knockout mice
developed hypertension and cardiac hypertrophy
associated with the activation of the renin-angiotensin system in the kidney and heart (12).
Despite the normalization of the serum calcium
and phosphorus levels, a calcium- and phosphorus-fortified diet neither normalized the blood
pressure nor suppressed the activity of the renin-angiotensin system in the 1α-hydroxylase
knockout mice. However, 1,25(OH)2D treatment led to the normalization of the activity of
the renin-angiotensin system and blood pressure.
In summary, the current literature indicates that
maintaining adequate vitamin D levels may be an
important consideration in the treatment of hypertension, especially in individuals with vitamin
D insufficiency and deficiency.
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